Quantcast
Last updated on April 19, 2014 at 1:20 EDT

Latest Verenium Corporation Stories

2011-02-25 07:00:00

SAN DIEGO, Feb. 25, 2011 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development and commercialization of high-performance industrial enzyme solutions, today announced a series of changes within its senior management team to take effect March 31: Carlos Riva, currently Director, President and Chief Executive Officer, will be retiring from his position at the Company. He will continue to be available to the Company as a consultant for a period of time. James...

2011-02-22 07:00:00

SAN DIEGO, Feb. 22, 2011 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development and commercialization of high-performance industrial enzyme solutions, today announced that it will release 2010 fourth quarter and year-end financial results on Tuesday, March 1, 2011 after market close. In conjunction with the release, the Company will host a conference call with live webcast on Tuesday, March 1 at 5:00 p.m. ET. The call may be accessed by dialing 877-755-7422...

2011-02-16 07:00:00

SAN DIEGO, Feb. 16, 2011 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development and commercialization of high-performance industrial enzyme solutions, today announced that James Levine, Executive Vice President and Chief Financial Officer, will present at the upcoming Jefferies 11th Global Clean Technology Conference. The presentation is scheduled to begin at 1:30 p.m. EST on Wednesday, February 23, 2011 in New York City. More information about this event,...

2011-01-12 00:00:00

DEL MAR, Calif., Jan. 12, 2011 /PRNewswire/ -- iDiverse today announced that Dr. Carl A. Miller has joined the company's Business and Scientific Advisory Board. "We are extremely pleased to have Dr. Miller join our team at this time," said John Burr, president and CEO of iDiverse. "Dr. Miller has over forty years of extensive, hands on experience in the commercialization of novel bio-based technologies that have greatly improved the economics of production of biofuels and biomaterials. He...

2011-01-06 07:00:00

CAMBRIDGE, Mass., Jan. 6, 2011 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development and commercialization of high-performance industrial enzyme solutions, today announced that the lawsuit filed by Capital Ventures International (CVI) against Verenium has been dismissed. Verenium's motion for summary judgment to dismiss CVI's complaint was granted by the United States District Court for the Southern District of New York. CVI's complaint related to a dispute...

2011-01-05 07:00:00

CAMBRIDGE, Mass., Jan. 5, 2011 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development and commercialization of high-performance industrial enzyme solutions, today announced that James Levine, Executive Vice President and Chief Financial Officer, will present at the upcoming Piper Jaffray Sixth Annual Clean Technology & Renewables Conference. The presentation is scheduled to begin at 3:00 p.m. EST on Wednesday, January 12, 2011 and will take place at The...

2010-12-14 07:00:00

CAMBRIDGE, Mass., Dec. 14, 2010 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development and commercialization of high-performance industrial enzyme solutions, today announced key 2010 accomplishments and 2011 Company goals and financial guidance. "2010 has been a significant year of transition for Verenium as we moved from being biofuels oriented to being focused on building the next leading industrial enzymes company," said Carlos Riva, Chief Executive...

2010-11-23 07:10:00

CAMBRIDGE, Mass., Nov. 23, 2010 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development and commercialization of high-performance industrial enzyme solutions, today announced that James Levine, Executive Vice President and Chief Financial Officer, will present at the upcoming Baird 2010 Clean Technology Conference. The presentation is scheduled to begin at 10:00 a.m. PST on Wednesday, December 1, 2010 and will take place at the Four Seasons Hotel in San...

2010-11-23 07:00:00

CAMBRIDGE, Mass., Nov. 23, 2010 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development and commercialization of high-performance enzymes solutions, today announced an agreement with Desmet Ballestra Group s.a., a leading global solutions provider in the field of engineering and delivery of installations and equipment for the edible oil and fats and biodiesel industries, to jointly market the Purifine enzymatic degumming process, which combines...

2010-11-09 15:05:00

CAMBRIDGE, Mass., Nov. 9, 2010 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development and commercialization of high-performance industrial enzyme solutions, today reported a summary of recent Company highlights and financial results for the third quarter of 2010. "I am pleased with the significant progress made across the business over the last quarter; we continue to see solid progress growing and diversifying our product sales and improved...